| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/09/1998 | WO1998014206A1 T cells mediating an immune response and methods of use |
| 04/09/1998 | WO1998014205A1 Cancer therapy using an oncogene product and a foreign mhc molecule |
| 04/09/1998 | WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | WO1998014170A1 Idiotypic vaccine in lipid based carrier for b cell disorders |
| 04/09/1998 | WO1998004710A3 Live recombinant bhv/brsv vaccine |
| 04/09/1998 | WO1998002547A3 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 04/09/1998 | WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2574049A1 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267645A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2242590A1 T cells mediating an immune response and methods of use |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834567A2 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834323A1 Cytokine gene therapy for treatment of malignacies |
| 04/08/1998 | EP0834322A2 Mycosis vaccine |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
| 04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 04/08/1998 | EP0833925A1 Diagnostic test for equine arteritis virus mediated disease |
| 04/08/1998 | EP0833923A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833920A2 Transferrin receptor genes |
| 04/08/1998 | EP0833919A1 Type f botulinum toxin and use thereof |
| 04/08/1998 | EP0833917A2 Malarial pre-erythrocytic stage polypeptide molecules |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833911A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833903A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 04/08/1998 | EP0833892A1 Human hepatoma-derived growth factor-2 |
| 04/08/1998 | EP0833890A1 Coanda effect gene delivery instrument and method of use |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833663A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
| 04/08/1998 | EP0833662A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 04/08/1998 | EP0833661A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |
| 04/08/1998 | EP0833660A1 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 04/08/1998 | EP0833658A1 Inhibin compositions and methods of enhancing production performance |
| 04/08/1998 | EP0833648A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES |
| 04/08/1998 | EP0833647A1 Method for treating tumors with a toxin |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833614A1 System and method for producing drug-loaded microparticles |
| 04/08/1998 | EP0638067B1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 04/08/1998 | EP0630405B1 Novel V28 seven transmembrane receptor |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | EP0539516B1 Asphodelus composition for increasing white blood cell count |
| 04/08/1998 | EP0256092B1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| 04/08/1998 | CN1178534A Isolated nucleic acid molecules as members of the Mage-Xp family and uses thereof |
| 04/08/1998 | CN1178472A Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 04/08/1998 | CN1178470A Collagen-based method and formulations for treatment of immune system-mediated diseases |
| 04/08/1998 | CN1178242A Specific antibody Anti 5-7 for pseudohypertrophic muscular dystrophy |
| 04/07/1998 | US5736524 Polynucleotide tuberculosis vaccine |
| 04/07/1998 | US5736507 Peptide of human cartilage glycoprotein 39, which stimulates autoreactive t-cells found in blood of rheumatoid arthritis patients |
| 04/07/1998 | US5736376 Recombinant endothelin converting enzyme-2 and its use in ECE inhibitor screening |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736367 Vectors and prokaryotes which autocatalytically delete antibiotic resistance |
| 04/07/1998 | US5736362 An isolated nucleic acid comprising nucleotide sequence encoding amino acid sequence 25-276 of a rye grass pollen protein |
| 04/07/1998 | US5736361 Production of gonorrheal PI proteins |
| 04/07/1998 | US5736347 Nucleic acids of Rochalimaea henselae and methods and compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infection |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/07/1998 | US5736319 Analyzing for absence of glycoproteins x or i in pseudorabies virus antigen-containing serum of animals (i.e. swine) to distinguish between vaccination and virulent infections |
| 04/07/1998 | US5736317 Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium |
| 04/07/1998 | US5736315 Methods and compositions for detecting anti-hepatitis E virus activity |
| 04/07/1998 | US5736165 Applying aqueous chlorine dioxide opthalmic antiseptic and surgical irrigant solution which is produced from a precursor prior to applying |
| 04/07/1998 | US5736149 Allergenic proteins and peptides from johnson grass pollen |
| 04/07/1998 | US5736148 Infectious Japanese encephalitis virus cDNA clones that produce highly attenuated recombinant Japanese encephalitis virus, and vaccines thereof |
| 04/07/1998 | US5736146 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 04/07/1998 | US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/07/1998 | US5736142 Alteration of immune response using pan DR-binding peptides |
| 04/07/1998 | US5736141 Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant |
| 04/07/1998 | US5736139 Treatment of Clostridium difficile induced disease |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736136 Immunoglobulin infusion in xenotransplantation |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | CA1339801C Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 04/07/1998 | CA1339798C Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans |
| 04/02/1998 | WO1998013501A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| 04/02/1998 | WO1998013500A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013493A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/02/1998 | WO1998013489A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 04/02/1998 | WO1998013388A1 Antibody against human parathormone related peptides |
| 04/02/1998 | WO1998013380A1 Snrnp sm proteins |
| 04/02/1998 | WO1998013067A1 Method of preventing acute rejection following solid organ transplantation |
| 04/02/1998 | WO1998013066A1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 04/02/1998 | WO1998013065A1 Rotavirus vaccine formulations |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |